Towards the immunoproteome of Neisseria meningitidis

PLoS ONE

Volumn 4, Issue 6, 2009, Pages

  Mendum, Tom A ^a   Newcombe, Jane ^a   McNeilly, Celia L ^a   McFadden, Johnjoe ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MENINGOCOCCUS VACCINE; RIBOSOME PROTEIN; BACTERIAL ANTIGEN; PROTEOME; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL; BACTERIAL IMMUNITY; CELL METABOLISM; CELL SURFACE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MENINGOCOCCOSIS; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; VACCINATION; ANIMAL; CHEMISTRY; CYTOPLASM; EPIDEMIC MENINGITIS; IMMUNE SYSTEM; IMMUNOLOGY; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; SEPSIS;

MUS; NEISSERIA MENINGITIDIS;

ANIMALS; ANTIGENS, BACTERIAL; CYTOPLASM; FEMALE; HUMANS; IMMUNE SYSTEM; IMMUNOGLOBULIN G; MASS SPECTROMETRY; MENINGITIS, MENINGOCOCCAL; MICE; NEISSERIA MENINGITIDIS; PROTEOME; PROTEOMICS; RECOMBINANT PROTEINS; SEPSIS;

EID: 67650135804     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005940     Document Type: Article

References (54)

1. Gray SJ, Trotter CL, Ramsay ME, Guiver M, Fox AJ, et al. (2006) Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. J Med Microbiol 55: 887-96.
2. Rodriguez AP, Dickinson F, Baly A, Martinez R (1999) The epidemiological impact of antimeningococcal B vaccination in Cuba. Mem Inst Oswaldo Cruz 94: 433-40.
3. Bjune G, Høiby EA, Grønnesby JK, Arnesen O, Fredriksen JH, et al. (1991) Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338: 1093-1096.
4. Martin D, Lopez L (2008) The Epidemiology of Meningococcal Disease in New Zealand in 2007. New Zealand Ministry of Health (http://www.moh. govt.nz).
5. Giuliani MM, Adu-Bobie J, Comanducci M, Aricò B, Savino S, et al. (2006) A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci 103: 10834-9.
6. Pollard AJ, Frasch C (2001) Development of natural immunity to Neisseria meningitidis. Vaccine 19: 1327-1346.
7. Goldschneider I, Gotschlich EC, Artenstein MS (1969) Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 129: 1307-26.
8. Goldschneider I, Gotschlich EC, Artenstein MS (1969) Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med 129: 1327-48.
9. Li Y, Sun YH, Ison C, Levine MM, Tang CM (2004) Vaccination with attenuated Neisseria meningitidis strains protects against challenge with live Meningococci. Infect Immun 72: 345-51.
10. Mandrell RE, Zollinger WD (1989) Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination. Infect Immun 57: 1590-8.
11. Mignogna G, Giorgi A, Stefanelli P, Neri A, Colotti G, et al. (2005) Inventory of the proteins in Neisseria meningitidis serogroup B strain MC58. J Proteome Res 4: 1361-70.
12. Bernardini G, Renzone G, Comanducci M, Mini R, Arena S, et al. (2004) Proteome analysis of Neisseria meningitidis serogroup A. Proteomics 4: 2893-926.
13. Abel A, Sánchez S, Arenas J, Criado MT, Ferreirós CM (2007) Bioinformatic analysis of outer membrane proteome of Neisseria meningitidis and Neisseria lactamica. Int Microbiol 10: 5-11.
14. Vaughan TE, Skipp PJ, O'Connor CD, Hudson MJ, Vipond R, et al. (2006) Proteomic analysis of Neisseria lactamica and Neisseria meningitidis outer membrane vesicle vaccine antigens. Vaccine 24: 5277-93.
15. Vipond C, Suker J, Jones C, Tang C, Feavers IM, et al. (2006) Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254. Proteomics 6:3400-13. Erratum in: Proteomics (2006) 6: 4203.
16. Uli L, Castellanos-Serra L, Betancourt L, Domínguez F, Barberáa R, et al. (2006) Outer membrane vesicles of the VA-MENGOC-BC vaccine against serogroup B of Neisseria meningitidis: Analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 6: 3389-99.
17. Abel A, Sánchez S, Arenas J, Criado MT, Ferreirós CM (2007) Bioinformatic analysis of outer membrane proteome of Neisseria meningitidis and Neisseria lactamica. Int Microbiol 10: 5-11.
18. Wheeler JX, Vipond C, Feavers IM (2007) Exploring the proteome of meningococcal outer membrane vesicle vaccines. Proteomics Clin Appl 1: 1198-1210.
19. Sinha S, Arora S, Kosalai K, Namane A, Pym AS, et al. (2002) Proteome analysis of the plasma membrane of mycobacterium tuberculosis. Comp Funct Genomics 3: 470-83.
20. Ling E, Feldman G, Portnoi M, Dagan R, Overweg K, et al. (2004) Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clin Exp Immunol 138: 290-8.
21. Sellman BR, Howell AP, Kelly-Boyd C, Baker SM (2005) Identification of immunogenic and serum binding proteins of Staphylococcus epidermidis. Infect Immun 73: 6591-600.
22. Fernández-Arenas E, Molero G, Nombela C, Diez-Orejas R, Gil C (2004) Low virulent strains of Candida albicans: unravelling the antigens for a future vaccine. Proteomics 4: 3007-20.
23. Spence JM, Clark VL (2000) Role of ribosomal protein L12 in gonococcal invasion of Hec1B cells. Infect Immun 68: 5002-10.
24. Spence JM, Tyler RE, Domaoal RA, Clark VL (2002) L12 enhances gonococcal transcytosis of polarized Hec1B cells via the lutropin receptor. Microb Pathog 32: 117-25.
25. Sanchez-Campillo M, Bini L, Comanducci M, Raggiaschi R, Marzocchi B, et al. (1999) Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera. Electrophoresis 20: 2269-79.
26. Oliveira SC, Splitter GA (1996) Immunization of mice with recombinant L7/ L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine 14: 959-62.
27. Nolte O, Förch C, Ehrhard I, Sonntag HG (2002) Immunogenicity of recombinant L7/L12 ribosomal protein of Neisseria meningitidis high prevalence of specific antibodies in humans but limited immunogenicity for T cells. Med Microbiol Immunol 191: 41-7.
28. Wilkins JC, Beighton D, Homer KA (2003) Effect of Acidic pH on Expression of Surface-Associated Proteins of Streptococcus oralis. Appl Environ Microbiol 69: 5290-5296.
29. Muhonen J, Vidgren J, Helle A, Yohannes G, Viitala T, et al. (2009) Interactions of fusidic acid and elongation factor G with lipid membranes. Anal Biochem 374: 133-42.
30. Lin YF, Wu MS, Chang CC, Lin SW, Lin JT, et al. (2006) Comparative immunoproteomics of identification and characterization of virulence factors from Helicobacter pylori related to gastric cancer. Mol Cell Proteomics 5: 1484-96.
31. Dallo SF, Kannan TR, Blaylock MW, Baseman JB (2002) Elongation factor Tu and E1 beta subunit of pyruvate dehydrogenase complex act as fibronectin binding proteins in Mycoplasma pneumoniae. Mol Microbiol 46: 1041-1051.
32. Marques MA, Chitale S, Brennan PJ, Pessolani MC (1998) Mapping and identification of the major cell wall-associated components of Mycobacterium leprae. Infect Immun 66: 2625-2631.
33. Granato D, Bergonzelli GE, Pridmore RD, Marvin L, Rouvet M, et al. (2004) Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins. Infect Immun 72: 2160-2169.
34. Lopez JE, Siems WF, Palmer GH, Brayton KA, McGuire TC, et al. (2005) Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping. Infect Immun 73: 8109-18.
35. Kunert A, Losse J, Gruszin C, Huhn M, Kaendler K, et al. (2007) Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein. J Immunol 179: 2979-88.
36. Klugman KP, Gotschlich EC, Blake MS (1989) Sequence of the structural gene (rmpM) for the class 4 outer membrane protein of Neisseria meningitidis, homology of the protein to gonococcal protein III and Escherichia coli OmpA, and construction of meningococcal strains that lack class 4 protein. Infect Immun 57: 2066-71.
37. Nowalk AJ, Gilmore Jr RD, Carroll JA (2006) Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteins. Infect Immun 74: 3864-73.
38. Padmalayam I, Anderson B, Kron M, Kelly T, Baumstark B (1997) The 75kilodalton antigen of Bartonella bacilliformis is a structural homolog of the cell division protein FtsZ. J Bacteriol 179: 4545-4552.
39. Pitarch A, Abian J, Carrascal M, Sánchez M, Nombela C, et al. (2004) Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies. Proteomics 4: 3084-106.
40. Delpino MV, Estein SM, Fossati CA, Baldi PC, Cassataro J (2007) Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice. Vaccine 25: 6721-9.
41. Knaust A, Weber MV, Hammerschmidt S, Bergmann S, Frosch M, et al. (2007) Cytosolic proteins contribute to surface plasminogen recruitment of Neisseria meningitidis. J Bacteriol 189: 3246-55.
42. Connolly JP, Comerci D, Alefantis TG, Walz A, Quan M, et al. (2006) Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development. Proteomics 6: 3767-80.
43. Ohman R, Ridell M (1996) Purification and characterisation of isocitrate dehydrogenase and malate dehydrogenase from Mycobacterium tuberculosis and evaluation of their potential as suitable antigens for the serodiagnosis of tuberculosis. Tuber Lung Dis 77: 454-61.
44. Mueller M, Bunk S, Diterich I, Weichel M, Rauter C, et al. (2006) Identification of Borrelia burgdorferi ribosomal protein L25 by the phage surface display method and evaluation of the protein's value for serodiagnosis. J Clin Microbiol 44: 3778-80.
45. Álvarez A, Martín A, Falcón V, de la Rosa MC, González-Blanco S, et al. (2004) Association of the P64k dihydrolipoamide dehydrogenase to the Neisseria meningitidis membrane. Biotecnología Aplicada 21: 137-42.
46. Guillén G, Alvarez A, Silva R, Morera V, González S, et al. (1998) Expression in Escherichia coli of the lpdA gene, protein sequence analysis and immunological characterization of the P64k protein from Neisseria meningitidis. Biotechnol Appl Biochem 27: 189-96.
47. Litt DJ, Savino S, Beddek A, Comanducci M, Sandiford C, et al. (2004) Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease. J Infect Dis 190: 1488-1497.
48. Ferrari G, Garaguso I, Adu-Bobie J, Doro F, Taddei AR, et al. (2006) Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles. Proteomics 6: 1856-1866.
49. Hsu C-A, Lin W-R, Li J-C, Tseng Y-T, Chang C-M, et al. (2008) Immunoproteomic identification of the hypothetical protein NMB1468 as a novel lipoprotein ubiquitous in Neisseria meningitidis with vaccine potential. Proteomics 8: 2115-2125.
50. Shah P, Marquart M, Quin LR, Swiatlo E (2006) Cellular location of polyamine transport protein PotD in Streptococcus pneumoniae. FEMS Microbiol Lett 261: 235-237.
51. Fredriksen JH, Rosenqvist E, Wedege E, Bryn K, Bjune G, et al. (1991) Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann 14: 67-79.
52. Mortz E, Krogh TN, Vorum H, Gòrg A (2001) Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 1: 1359-63.
53. Bjorvatn B, Lund V, Kristiansen BE, Korsnes L, Spanne O, et al. (1984) Applications of restriction endonuclease fingerprinting of chromosomal DNA of Neisseria meningitidis. J Clin Microbiol 19: 763-5.
54. Borrow R, Carlone GM (2001) Serogroup B and C Serum Bactericidal Assays. 289-304. In: Pollard AJ, Maiden MCJ, eds (2001) Meningococcal vaccines, methods and protocols. New Jersey: Humana Press.